AGRIBIOTECH INC
424B2, 1999-09-28
AGRICULTURAL PRODUCTION-CROPS
Previous: COLLEGE TELEVISION NETWORK INC, DEF 14C, 1999-09-28
Next: MERRILL LYNCH ARIZONA MUNICIPAL BD FD OF MLMSMST, 485APOS, 1999-09-28




                                                Filed Pursuant to Rule 424(b)(2)
                                            Registration Statement No. 333-61097

                         SUPPLEMENT TO AGRIBIOTECH, INC.
                        PROSPECTUS DATED AUGUST 14, 1998
                AS PREVIOUSLY SUPPLEMENTED ON SEPTEMBER 4, 1998,
    DECEMBER 29, 1998, JANUARY 22, 1999, FEBRUARY 5, 1999, AND JUNE 29, 1999
                      ___________________________________


The offering:

Shares of common stock offered...... 480,000 shares issued to Thomas K.
                                     Hodges and Halina K. Hodges (400,000
                                     shares), and Bill L. Rose, L.L.C. (80,000
                                     shares) as additional consideration in
                                     connection with ABT's acquisition of
                                     HybriGene, LLC from the Hodges and Rose.

Price of common stock............... On September 23, 1999, the closing sale
                                     price of ABT common stock on the Nasdaq
                                     National Market was $4 5/16 per share.

Nasdaq National Market symbol....... ABTX

                      ___________________________________

     The shares offered hereby involve a high degree of risk. See "Risk Factors"
beginning on page 4.

     Neither the  Securities and Exchange  Commission  nor any state  securities
commission  has  approved or  disapproved  these  securities  or passed upon the
accuracy or adequacy of this prospectus. Any representation to the contrary is a
criminal offense.
                      ___________________________________

                                  September 24, 1999

<PAGE>

ABOUT THIS PROSPECTUS SUPPLEMENT

     This prospectus supplement is part of a registration  statement on Form S-4
we filed with the SEC on August 14, 1998. The prospectus  that we filed included
a general  description of the  securities  that we may offer at any time for two
years from that date.  This  supplement  contains  information  included  in the
August 14, 1998  prospectus  and updated  information  and specific  information
about the securities being offered under this prospectus supplement.

     This  prospectus  supplement  relates to 480,000 shares of our common stock
that we are issuing to Thomas K.  Hodges,  Halina K.  Hodges,  and Bill L. Rose,
L.L.C.,  as additional  consideration  in connection  with ABT's  acquisition of
HybriGene, LLC from the Hodges and Rose. The shares of common stock are referred
to in this  prospectus  supplement  as the  "shares" and were  registered  as an
original equity issuances as part of this registration statement.

     To  fully  understand  this  offering,  you  should  read  this  prospectus
supplement and the additional information described under the heading "Where You
Can Find More Information."

                                TABLE OF CONTENTS

<TABLE>
<S>                                                              <C>

PROSPECTUS SUMMARY..............................................  -3-

RISK FACTORS....................................................  -4-

WHERE YOU CAN FIND MORE INFORMATION............................. -11-

USE OF PROCEEDS................................................. -12-

DIVIDEND POLICY................................................. -13-

PRICE RANGE OF COMMON STOCK..................................... -13-

RECENT DEVELOPMENTS............................................. -14-

DESCRIPTION OF CAPITAL STOCK.................................... -15-

PLAN OF DISTRIBUTION............................................ -16-

COMMISSION POSITION ON INDEMNIFICATION
     FOR SECURITIES ACT LIABILITIES............................. -16-

LEGAL MATTERS................................................... -16-

EXPERTS......................................................... -17-
</TABLE>
                                       -2-
<PAGE>

                               PROSPECTUS SUMMARY

     This  summary   highlights   selected   information  from  this  prospectus
supplement and may not contain all the information  that is important to you. To
understand  the  circumstances  and  terms  of the  offering  and  for  complete
information  about ABT, you should read this entire document and the information
incorporated by reference,  including the financial  statements and the notes to
the financial  statements.  Unless  otherwise  stated,  all references to fiscal
years are to a June 30 year end.

THE COMPANY

     ABT is the  largest  agricultural  seed  company in the United  States that
specializes in developing,  processing,  packaging and distributing varieties of
forage crops, in which the entire plant is harvested for livestock  consumption,
and cool-season turfgrass seeds, seed used in home-lawns,  golf courses,  parks,
cemeteries  and roadway  medians.  Since January 1, 1995,  we have  completed 34
acquisitions and,  including net sales from the businesses we have acquired,  we
have grown  from net sales of  $29,000 in fiscal  1994 to pro forma net sales of
approximately  $409 million for fiscal  1998.  We own all elements of our forage
and  turfgrass  seed  operations  including  traditional  genetic  breeding,  by
breeding  varieties with desirable  traits  together to form a new variety,  and
research and development programs,  seed processing plants that clean, condition
and package seed grown under  contract  for us, and  national and  international
sales and distribution networks.  This means that we are a vertically integrated
business. ABT's headquarters are located at 120 Corporate Park Drive, Henderson,
NV 89014; telephone (702) 566-2440.

THE OFFERING

     On January 22, 1999,  ABT completed the  acquisition  of 100% of the issued
and outstanding  share capital of HybriGene,  LLC, an Indiana limited  liability
company, from Thomas K. Hodges, Halina K. Hodges, individuals, and Bill L. Rose,
L.L.C., an Oregon limited liability  company,  under a stock purchase  agreement
dated  January  22,  1999.  HybriGene,  LLC has been  engaged  in  research  and
development  concerning the use of genetic  technology in the farming  industry.
The aggregate  purchase  price was $11.5  million,  paid as follows:  Thomas and
Halina  Hodges - $9.5  million  in the form of  515,000  shares of ABT's  common
stock;  Bill L. Rose,  L.L.C. - $100,000 in cash and $1.9 million in the form of
103,012 shares of ABT's common stock.

     The issuances of the shares of common stock were registered as described in
the  prospectus  supplement  dated February 5, 1999 and may be resold subject to
the terms of lock-up  agreements  between the recipients of ABT common stock and
ABT.  You will find  additional  information  including  financial  information,
concerning  HybriGene,  LLC in our Current  Report on Form 8-K dated January 22,
1999,  and filed on February 5, 1999,  which is  incorporated  by reference into
this prospectus supplement.

     In the above transaction, ABT guaranteed the recipients of ABT common stock
that the amount they would  receive  upon sale of the ABT shares would equal the
agreed-upon  value of those shares,  provided the shares were sold in accordance
with the terms of the lock-up  agreements.  In  addition,  ABT is to receive any
proceeds  that  exceed the  agreed-upon  value of the  shares.  ABT may  satisfy
obligations with respect to the guarantees by issuing  additional  shares of ABT
common stock or by making cash payments, at ABT's option. Due to declines in the
price of ABT's common stock since these arrangements were agreed to, proceeds of
sales  of  shares  have not been  sufficient  to  satisfy  the  guarantees.  The
recipients  agreed to  suspend  sales of ABT  common  stock  from  April 1, 1999
through  June 30,  1999 and ABT agreed to make cash  payments  aggregating  $1.3
million  to  certain  of these  recipients.  These  payments  have been made and
credited  against the  guaranteed  proceeds.  In  addition,  ABT  granted  these
recipients  options to buy an aggregate of 95,000  shares of ABT common stock at
$5.00 per share, which equaled the market price at the time of grant.

     ABT agreed with these recipients to issue an additional 1,000,000 shares of
ABT common stock to them on June 29, 1999,  the proceeds  from the sale of which
will  be  credited  against  the  guaranteed  proceeds.  ABT is now  issuing  an
additional  480,000 shares of common stock to them. If the shares remaining from
the previous  issuances and the additional shares are sold realizing average net
proceeds of $5.00 per share, the total received by these recipients will satisfy
all amounts due under the guarantees. If the net proceeds realized from the sale
of the shares  averages less than $5.00 per share,  ABT has the option of paying
cash or issuing  additional shares of common stock to satisfy the shortfall,  in
certain circumstances.

                                       -3-
<PAGE>

                                  RISK FACTORS


     Before  you  invest in our  securities,  you should be aware that there are
various risks,  including those described  below,  that may affect our business,
financial  condition and results of operations.  We caution you,  however,  that
this list of risk factors may not be all inclusive.

     Potential Material Adverse Effects If We Are Unable to Manage Recent Rapid
     --------------------------------------------------------------------------
     Growth from Net Sales of $26 Million in Fiscal 1996 to Pro Forma Net Sales
     --------------------------------------------------------------------------
     of $409 Million for Fiscal 1998.
     -------------------------------

     We have  acquired all or part of 34  businesses in the forage and turfgrass
seed sector since  January 1, 1995. As a result of these  acquisitions,  we have
experienced  significant revenue growth and expanded the number of our employees
and the geographic scope of our operations.  We recently  reorganized our senior
management.  The founders of ABT are no longer members of senior management.  We
have a new Chief Executive Officer, a new President/Chief Operating Officer, two
Executive  Vice-Presidents  and  a  Senior  Vice-President,   who  have  overall
responsibility  for managing ABT. These changes were put into effect in February
through June 1999. Therefore,  we cannot assure you that our new management will
be able to successfully  manage our growth. This rapid growth has placed and may
continue to place significant  demands on our management,  technical,  financial
and other  resources.  To manage  growth  effectively,  we will need to  improve
operational,  financial  and  management  information  systems,  procedures  and
controls. We may not be able to manage future growth effectively, and failure to
do so could have a material adverse effect on our business,  financial condition
and/or operating results. See "Management's Discussion and Analysis of Financial
Condition  and  Results of  Operations"  in the 1998 Form 10-K and the March 31,
1999 Form 10-Q  (collectively,  the  "MD&A"),  and  "Description  of  Business -
Acquisition Program" in the 1998 Form 10-K.

     Possible Failure to Effectively and Profitably Integrate Our 34
     ---------------------------------------------------------------
     Acquisitions May Result in Continued Losses.
     -------------------------------------------

     Our future  success  depends upon our ability to combine or  integrate  the
operations  of the  businesses  we have  acquired  into a vertically  integrated
company  which   represents  all  aspects  of  the  forage  and  turfgrass  seed
production,  research  and  distribution  process.  If  we  cannot  successfully
integrate  all of the  businesses  we have  acquired,  our  business,  financial
condition and/or operating results may be materially  adversely  affected and we
would not expect to operate profitably.  To successfully  integrate the acquired
businesses,  we must realize cost efficiencies without losing sales and margins.
As part of the process of  integrating  the  businesses  acquired,  we initially
announced  that we expected  to record a one-time  expense of between $5 million
and $15 million  during fiscal 1999.  This will consist  mainly of severance and
employment related costs and the closing of certain  facilities.  We will record
the large majority of the restructuring and other non-recurring  special charges
related to the integration in the forth quarter of FY1999 results. These charges
are  estimated to be in the middle of the  previously  announced  range.  We are
currently  completing  property  appraisals that will allow the final amounts of
the  charges  to  be  determined.   Certain   special  charges  related  to  the
restructuring, for example, personnel relocation costs and machinery relocation,
estimated  at less than $2.0  million  will be  recognized  in the first half of
FY2000.  The cost savings  resulting from the  integration  plan are expected to
exceed $14.0 million on an  annualized  basis.  In addition,  we have recorded a
significant amount of goodwill relating to our acquisitions. Although we believe
that goodwill is  recoverable  from future  operations in our current  operating
structure,  as part of our  restructuring,  it is possible  that some portion of
goodwill  will  become  impaired  and  written-down  as a non-cash  expenditure.
Despite these significant changes, we need to maintain product lines, brands and
facilities  in  order  to keep  our  customers  satisfied.  In  addition,  ABT's
integration  efforts  are being  carried out by a new  management  team who were
hired because of their operating backgrounds,  but have worked together only for
a short time. See "MD&A" and "Description of Business - Acquisition  Program" in
the 1998 Form 10-K.

     No Assurance of ABT's Ability to Continue to Grow Since We Relied on
     --------------------------------------------------------------------
     Acquisitions to Grow and Do Not Intend to Make Many Acquisitions in the
     -----------------------------------------------------------------------
     Future.
     ------

     We have experienced significant growth in net sales, from approximately $26
million in fiscal 1996 to $66  million in fiscal  1997,  $205  million in fiscal
1998 and pro forma net sales of  approximately  $409  million  for fiscal  1998,
reflecting the sale of the fertilizer division of Willamette Seed Company. While
we have achieved this growth through acquisitions, we do not intend to make many
acquisitions  in the future and may sell  individual or groups of assets as part
of our  integration  plans.  Our  future  growth  depends  upon our  ability  to
integrate our operations, and to increase sales from existing operations. We may
not be  successful  in  expanding  existing  operations  because we operate in a

                                       -4-
<PAGE>

highly  competitive  industry,  which is  highly  cyclical  due to  weather  and
consumer  demand and is subject  to  numerous  other  risks  described,  in this
prospectus supplement.

     Potential Undiscovered Liabilities Associated with ABT's 34 Acquisitions.
     ------------------------------------------------------------------------

     The businesses that we have acquired may have existing  liabilities that we
may have been unable to discover during our  pre-acquisition  investigation.  If
liabilities  are  discovered,  we could have  liabilities  that  result from the
conduct of prior owners of the  businesses  and our operations may be materially
adversely affected. These liabilities may arise from environmental contamination
or  non-compliance  by  prior  owners  with  environmental  laws  or  regulatory
requirements.  Any  indemnities or warranties  that we receive from prior owners
may not fully cover these  liabilities  due to their  limited  scope,  amount or
duration, the limited finances of the sellers, or for other reasons.

     Possible Inability of ABT to Develop New Genetically Superior
     -------------------------------------------------------------
     Products.
     --------

     We are developing new,  genetically superior forage and turfgrass varieties
that we  believe  will  play a key  role in our  success.  If we are not able to
develop and successfully market genetically  superior strains either through our
own efforts or with industry  partners,  our business,  financial  condition and
results of operations may be materially adversely affected.  See "Description of
Business--Research and Development" in the 1998 Form 10-K.

     Possible Inability to Obtain Market Acceptance for Genetically Superior
     -----------------------------------------------------------------------
     Varieties May Adversely Affect Profitability.
     --------------------------------------------

     Even if we are  successful in developing  genetically  superior  forage and
turfgrass  varieties,  there can be no assurance that there will be a market for
these products.  Even if a market for these products  develops,  there can be no
assurance  that we  will  recover  the  costs  associated  with  developing  and
marketing  them.  If we cannot  effectively  market new products we develop,  at
prices  sufficient to cover costs and generate  adequate return on capital,  our
business,  financial  condition  and  results of  operations  may be  materially
adversely affected.

     Dependence on Rights for Forage and Turfgrass Varieties.
     -------------------------------------------------------

     We own the rights to a number of forage and  turfgrass  varieties  that are
protected  under the Plant  Variety  Protection  Act and are  seeking to acquire
and/or  develop  other  protected  varieties.  These  rights may be  challenged,
invalidated or circumvented.  In addition, others could claim that products that
we develop violate their rights. We may incur substantial costs in asserting our
rights against others,  and/or defending any infringement  suits brought against
us by others. See "Description of Business--Proprietary Rights" in the 1998 Form
10-K.

     Possible Inability to Obtain Third Parties' Biotechnology or Lack of
     --------------------------------------------------------------------
     Market Acceptance May Adversely Affect Profit Margins.
     -----------------------------------------------------

     Breakthroughs  in  biotechnology  have  led to  the  introduction  of  new,
improved and specialized seeds in the corn, soybean and cotton seed sectors.  We
believe  that  similar  biotechnology   breakthroughs  will  also  lead  to  the
introduction of enhanced seeds in the forage and turfgrass seed sector. However,
if we are unable to obtain those biotechnology  breakthroughs we may not be able
to improve our margins and profitability as was accomplished in these other seed
sectors.  Our  objective  is to become the  licensee or partner of choice in our
seed  sector  for  owners of new  genetic  traits in plants  for crops that were
developed through biotechnology,  or genetic engineering.  These genetic traits,
which  increase  the  value  of the  crop  grown  from the  seed,  are  known as
value-added  genetic traits. If we cannot license or develop value-added genetic
traits,  or if we cannot develop and market products from these traits at prices
sufficient to cover costs and generate adequate return on capital, our business,
financial  condition  and  results of  operations  may be  materially  adversely
affected.   Furthermore,   there  has  been  significant  resistance  abroad  to
genetically  modified  food crops which could affect  market  acceptance  in the
United States for those crops.  ABT's focus is on forage and turfgrass seed, not
on seed for food crops.  Although  ABT  currently  sells only a minor  amount of
genetically  modified seeds, a significant  lack of market  acceptance for these
seeds could have a material negative impact on ABT's  anticipated  future profit
margins.  See  "Description  of  Business--Proprietary  Rights" in the 1998 Form
10-K.

                                      -5-
<PAGE>

     Possible Inability to be Competitive Against Large Agricultural Seed
     --------------------------------------------------------------------
     Companies, Who May Decide to Compete Against ABT, as Well as Numerous
     ---------------------------------------------------------------------
     Large Regional Seed Companies and Numerous Small Family Seed Businesses.
     -----------------------------------------------------------------------

     The seed industry and the field of agricultural  technology are both highly
competitive.  The major  agricultural  seed companies in the United States focus
their sales around hybrid seed corn,  including  Pioneer Hi-Bred  International,
DEKALB Genetics Corporation,  Novartis AG and Mycogen Corporation,  cotton seed,
including Delta and Pine Land Company and other grain crops. In the past,  these
companies have treated forage and turfgrass  seeds as secondary  crops.  This is
the opposite of our business  strategy,  which is to treat forage and  turfgrass
seed as our primary product.  Therefore, our major competitors in the forage and
turfgrass seed sector currently are large regional  companies and numerous small
family seed businesses.

     Our largest  United  States  competitors  for alfalfa  seed are  Cenex/Land
O'Lakes/Research Seed, Helena/AgriPro, Pioneer and Cal/West Seeds, each of which
we estimate has annual  alfalfa  seed sales of between $20 and $60 million.  Our
largest competitors for forages other than alfalfa are FFR Research and its farm
cooperative members. We also compete with small family owned businesses that are
strong  competitors in small geographic  areas. For cool- season turfgrass seed,
we compete with a number of companies  that have annual sales of between $20 and
$80 million. Most of these companies are regional companies with only Pennington
Seed,  which is owned by Central  Garden and Pet Company,  and O.M. Scott having
national brand name acceptance.

     Although  many of our  competitors  are small family owned  businesses  and
regional  companies,  any of the major agricultural seed companies may decide to
intensify  their  efforts in the forage and  turfgrass  seed  sector and compete
against us. We may not be able to compete  successfully against these companies.
These competitive  factors could have a material adverse effect on the Company's
business,  results of operation and/or financial condition.  See "Description of
Business--Competition" in the 1998 Form 10-K.

     Lack of Historical Profitability; Accumulated Deficit of Approximately $24
     --------------------------------------------------------------------------
     Million as of March 31, 1999.
     ----------------------------

     Over the life of ABT, we have not shown consistent  profitability.  We have
reported only four  profitable  quarters since becoming a publicly owned company
in  September  1993 and fiscal  1998 was our first  profitable  year.  We had an
accumulated  deficit of $24,249,486  through March 31, 1999 which includes a net
loss of $12,211,646  for the  nine-month  period ended March 31, 1999. The March
31,  1999  amounts do not  reflect  operations  for the fourth  quarter of ABT's
fiscal year ended June 30,  1999.  They also do not include the  majority of the
restructuring and other special charges  discussed above. In addition,  ABT also
incurred  additional  bad debt and inventory  reserves in the fourth  quarter of
fiscal 1999 associated with the Chapter 11 bankrupcy  filing by a major customer
(Hechinger  Co.) and inventory  redundancy  relating to integration  and product
line consolidation.  These additional reserves are not classified or included in
special charges.  As a result of these reserves,  the extraordinary  loss on the
May 1999  redemption of ABT's  subordinated  convertible  debentures,  and other
redundant operating costs, ABT will have a significant loss for fiscal 1999.

     Possible Inability to Fund Debt Service Costs of Approximately $11 Million
     --------------------------------------------------------------------------
     Per Year on Substantial Indebtedness of Approximately $77 Million;
     ------------------------------------------------------------------
     Effects of Financial Leverage.
     -----------------------------

     We have  indebtedness  that is substantial in relation to our stockholders'
equity, and interest and debt service requirements that are significant compared
to our cash flow from operations.  Our cash flow from  operations,  to date, has
not been  sufficient  to meet our debt service  obligations  without  additional
equity and debt  financings.  We have a revolving credit facility with financial
institutions under which we may incur up to $100 million of indebtedness subject
to a borrowing base computation and compliance with financial  covenants.  As of
September  24,  1999,  we had  borrowed  approximately  $60  million  under  the
revolving  credit  facility  and  approximately  $6 million was  available to be
borrowed.  In addition,  we have outstanding  approximately $17 million of other
long-term obligations. The annual debt service requirements, including scheduled
debt  repayments  and interest,  on this debt total  approximately  $11 million,
reflecting  anticipated  average borrowings under our revolving credit facility.
Weaknesses in the  agricultural  economy and the  bankruptcy of a major customer
(Hechinger Co.) have negatively impacted availability under our revolving credit

                                       -6-
<PAGE>

facility.  It is possible we may not have sufficient funds in the future to meet
our obligations under the revolving credit facility and other  indebtedness.  We
are currently exploring financing alternatives, including leveraging real estate
assets that are not now  encumbered,  to supplement,  or possibly  replace,  our
current revolving credit facilities. It is also possible we may issue additional
equity to fund operations.  ABT is in the due diligence process with undisclosed
major financial institutions for an asset-based long-term debt financing that is
expected to close by late October or early November 1999.

     The degree to which we are leveraged  could have important  consequences to
you. For example:

     .    our level of indebtedness  could make it more difficult to satisfy our
          debt repayment obligations;

     .    our level of indebtedness  could increase our vulnerability to general
          adverse economic and industry conditions;

     .    a  substantial  portion  of our  cash  flow  from  operations  must be
          dedicated  to  debt  service  and is,  therefore,  not  available  for
          operations and other purposes;

     .    our ability to obtain  additional  financing in the future for working
          capital, capital expenditures, acquisitions, research and development,
          or general corporate purposes may be impaired;

     .    our leverage  position and covenants in the revolving  credit facility
          could  limit  our  ability  to  expand,   compete  and  make   capital
          improvements; and

     .    our  borrowings  under  the  revolving  credit  facility  are and will
          continue to be at variable rates of interest,  which exposes us to the
          risk of increased interest rates.

     Our ability to pay interest on the revolving credit facility and to satisfy
our  other   obligations   depends  upon  our  future  financial  and  operating
performance.  Our  financial  and  operating  performance  may  be  affected  by
prevailing economic conditions and financial, business, competitive,  regulatory
and other factors that are beyond our control.  This is particularly  true as we
continue to expand operations. If we are unable to service our indebtedness,  we
will be forced to adopt an  alternative  strategy  that may include  reducing or
delaying capital expenditures,  scaling back expansion efforts,  selling assets,
restructuring or refinancing  indebtedness or seeking additional equity capital.
We may not be able to implement any of these  strategies on terms  acceptable to
us. See "MD&A."

     Risk of Foreclosure Due to Possible Violations of Restrictions Imposed on
     -------------------------------------------------------------------------
     ABT by Terms of Bank Indebtedness.
     ---------------------------------

     Our revolving credit facility with our lenders contains  restrictions  that
limit us in many ways. A breach of any of these  covenants  could  constitute an
event of default under this  agreement.  These  restrictions  may  significantly
limit  or  prohibit  us  from  incurring  indebtedness,  making  prepayments  of
indebtedness, paying dividends, making investments or acquisitions,  engaging in
transactions  with  affiliates,  creating liens,  selling assets and engaging in
mergers  and  corporate  consolidations.  The  revolving  credit  facility  also
requires  us to  maintain  specified  financial  ratios and to  satisfy  various
financial  condition  tests.  If  there  were an  event of  default  under  this
agreement, the lenders could declare the total amount outstanding, together with
accrued interest,  immediately due and payable. If we were unable to repay those
amounts,  the bank could  proceed to foreclose  their  security  interest in the
collateral  securing the  indebtedness,  which consists of substantially  all of
ABT's assets, except real estate. See "MD&A."

                                       -7-
<PAGE>

     Current Need for Additional Capital.
     -----------------------------------

     Our capital  requirements have been and are expected to remain significant.
We will need additional  capital to fund operations until we achieve and sustain
profitability.  If we are unable to obtain additional capital, we will be unable
to continue to grow.  Our capital  requirements  depend on many  factors.  These
factors include the timing and cost of future acquisitions, if any, the time and
cost involved in integrating our acquired  companies,  recent  weaknesses in the
agricultural  economy and our success at expanding existing  operations.  We may
need to seek  additional  capital and/or an increase in or an alternative to the
revolving credit facility to finance increased  operating or integration  needs,
or cutback operations resulting from, among other things,  unexpected changes in
seasonality or weather  patterns,  or if our  integration  plans are more costly
than anticipated. See "MD&A."

     Dependence on Key Personnel.
     ---------------------------

     Our success  depends in large part on the efforts,  abilities and expertise
of our executive  officers.  The founders of ABT are no longer members of senior
management  and the new  management  structure  consisting of a Chief  Executive
Officer, a President/Chief Operating Officer, two Executive Vice-Presidents, and
a  Senior  Vice-President  is  completely  responsible  for  implementing  ABT's
integration  efforts and  restructuring.  The loss of any of these key personnel
could have a material  adverse effect on our business,  financial  condition and
results  of  operations.  Along  with our  integration  efforts,  we are  hiring
qualified  marketing,   financial,  management  information  system,  and  other
technical personnel,  upon whom our prospects depend.  Competition for qualified
personnel is intense and there can be no assurance that we will be successful in
attracting or retaining such personnel. See "Management" in the 1998 Form 10-K.

     Operating Results May Fluctuate Due To Cyclical Nature of Agricultural
     ----------------------------------------------------------------------
     Products and Weather Patterns.
     -----------------------------

     Most  agricultural  products,  including  forage and  turfgrass  seed,  are
commodities  that are subject to wide  fluctuations in price based on supply and
demand.  This could result in large  fluctuations  in our results of  operations
between  quarters.  Demand for seed by farmers is determined by the general farm
economy. In addition, a variety of nature's adversities affect the production of
seed.  For example,  drought,  wind,  hail,  disease,  insects,  early frost and
numerous other forces could adversely  affect the growing of seed in any growing
season. Furthermore,  ABT's ability to package and deliver needed seed inventory
is dependant,  in part, on weather in the regions where seed is grown. Likewise,
actual  customer  orders and purchases  are  partially  dependant on the weather
where  the seeds are to be  planted.  See  "MD&A--Seasonality  of  Business  and
Quarterly Comparisons" in the 1998 Form 10-K.

     Seasonal Fluctuations of Quarterly Results.
     ------------------------------------------

     Our sales are  subject  to wide  seasonal  fluctuations  that  reflect  the
typical purchasing and growing patterns for forage crops and turfgrass.  Results
of  operations  from quarter to quarter do not  necessarily  reflect the results
that may be expected for any other interim period, or for the entire year. Also,
because  the  purchasing  and  growing  patterns  are  different  for forage and
turfgrass  seeds, our sales are affected by the breakdown of our product mix. In
addition,  weather affects commodity prices,  seed yields and planting decisions
by farmers. See "MD&A--Seasonality of Business and Quarterly Comparisons" in the
1998 Form 10-K.

                                       -8-
<PAGE>

     Costs of Complying with Department of Agriculture, Food and Drug
     ----------------------------------------------------------------
     Administration, Environmental Protection Agency and Various State
     -----------------------------------------------------------------
     Government Regulations.
     ----------------------

     Our operations are directly and indirectly  subject to various  Federal and
state  environmental   controls  and  regulations.   If  existing  environmental
regulations are changed,  or additional laws or regulations are passed, the cost
of  complying  with those  laws may be  substantial.  We believe  that we are in
substantial compliance with existing environmental  regulations.  However, these
regulations may be changed with  retroactive  effect and new laws or regulations
may be passed at any time.

     The  United   States   Department  of   Agriculture,   the  Food  and  Drug
Administration,  the Environmental Protection Agency, and various state agencies
regulate the development of seed of genetically  altered plants.  The regulatory
agencies that administer  existing or future  regulations or legislation may not
allow us to  produce  and market  genetically  engineered  seed.  Even if we are
legally permitted to produce and market genetically engineered seed, existing or
future  regulations  and  legislation  may  prevent us from doing so in a timely
manner  or  under   technically  or  commercially   feasible   conditions.   See
"Description of Business-Government Regulation" in the 1998 Form 10-K.

     Adverse Effect of Potential Future Sales of Common Stock.
     --------------------------------------------------------

     As of September 13, 1999, we had  48,921,281  shares of common stock issued
and outstanding. Of these shares, approximately 6,640,000 shares are "restricted
securities" as that term is defined in Rule 144 under the Securities  Act. It is
possible  that the sale of these  restricted  shares,  or even the potential for
these sales,  may have a  depressive  effect on the price of our common stock in
the public trading  market.  Any  depressive  effect could impair our ability to
raise  additional  equity  capital.  All but  approximately  1,000,000  of these
restricted shares, which are currently available for resale under Rule 144, have
been registered for resale under the Securities Act. We also have  approximately
9.1 million shares of common stock  available for issuance  without  restriction
upon  exercise of  outstanding  options and 3.2 million  shares of common  stock
available  for  issuance  without   restriction  upon  exercise  of  outstanding
warrants.  We cannot  predict  what effect sales of these shares may have on the
existing market price of our common stock.

     Holders of restricted  securities must satisfy the prospectus  delivery and
other  requirements  of the  Securities  Act  prior to  making  any sales of the
shares, unless the sales are made in accordance with the provisions of Rule 144.
Under  Rule  144,  if we are  in  compliance  with  various  public  information
requirements,  holders of restricted  securities that have held those securities
for at least one year may sell  limited  amounts of those  securities.  Rule 144
also permits  non-affiliates  to sell  restricted  securities free of any volume
limitations if those securities have been held for at least two years.

                                       -9-
<PAGE>

     Public Market Risks; Volatility of ABT Securities Prices.
     --------------------------------------------------------

     The market  price for our  securities  has been and may continue to be very
volatile.  Factors such as our financial results,  financing efforts, changes in
earnings  estimates  by  analysts,  litigation,  conditions  in our business and
various  factors  affecting  the  agriculture  industry  generally  may  have  a
significant  impact on the market  price of our  securities.  If, in some future
quarter, our operating results are below the expectations of analysts, which has
occurred in the past, the price of our  securities  may be materially  adversely
affected.  These  factors and general  economic and market  trends may adversely
affect the price of our securities. Additionally, in the last several years, the
stock market has experienced a high level of price and volume volatility. During
this  period  the  market  prices  for many  companies,  particularly  small and
emerging growth companies like ours, have  experienced  wide price  fluctuations
and  volatility  that  have  not  necessarily  been  related  to  the  operating
performance  of those  companies.  Our  operating  results  are also  tracked by
professional  analysts.  See "Market for Common  Equity and Related  Stockholder
Matters" in the 1998 Form 10-K.

     Management Information Systems and the Year 2000 Risks.
     ------------------------------------------------------

     As of August 1, 1999 all of the Company's domestic information systems were
Year 2000  ready.  Domestic  operations  constitute  approximately  96.4% of the
Company's  annual  revenue.  This was in large part  accomplished  by  migrating
approximately  86.5% of domestic  operations to an Enterprise  Resource Planning
("ERP")  information system and the remaining 13.5% will continue on an existing
system  that is Year  2000  ready.  ABT is in the  process  of  integrating  its
Canadian  operations  into its ERP  information  system and has  contracted  for
software,  hardware and  consulting  services to implement  this  integration by
October 1999. The ABT's operations in Mexico will be converted to an independent
Year 2000  platform by November  1999.  The  conversion  of these  international
operations will complete our internal Year 2000  information  systems  readiness
project. The cost of this implementation is not expected to exceed $8.5 million,
which amount includes internal costs for personnel,  training,  supplies, travel
and equipment.  At June 30, 1999, ABT had incurred approximately $8.2 million of
these costs. The implementation costs are funded through operations,  the credit
facilities described above, and approximately  $875,000 of financing provided by
one of the vendors.

     The ERP and related  network and  hardware  systems are designed to be Year
2000 compliant.  Local area networks,  desktop  hardware,  and desktop operating
systems for domestic  operations are Year 2000 ready.  International  operations
are  planned  to be Year 2000 ready by  November  1999 as a result of the system
integration and migration.

     ABT believes  that it has allocated  adequate  resources to ensure that all
information systems are Year 2000 ready. ABT expects its Year 2000 program to be
successfully  completed  on a timely  basis  prior to January 1, 2000.  However,
there  can be no  assurance  that this  will be  accomplished.  In the event any
operating units remain Year 2000  non-compliant in late 1999, ABT's  contingency
plan is twofold. First, ABT has identified reparation for existing software that
is available as an upgrade,  patch, or software  replacement  (data field masks,
editing date related computations, or as a temporary workaround).  Secondly, ABT
has  identified  the potential to  encapsulate  data  information as a temporary
measure  until the  software  or  systems  can be  replaced.  In the worst  case
scenario,  ABT  can  resort  at the  operating  unit  level  to  simple  desktop
accounting packages that are Year 2000 compliant. ABT estimates that the overall
risk to its  operations  as a result  of  non-compliance  with Year 2000 for its
existing  systems in a worst case  scenario to be less than  $100,000.  However,
there can be no assurance that this estimate is the absolute maximum.

     The  ability  of  third  parties  with  which  ABT  transacts  business  to
adequately  address their Year 2000 issues is outside of ABT's control.  ABT has
taken steps to confirm that the systems of its  suppliers and customers are Year
2000 compliant and to determine  whether the nature of any  noncompliance  would
have a  material  adverse  effect on ABT's  business,  financial  condition  and
results of operations.  ABT had previously  identified what it considered  major
customers and vendors.  Each identified company was sent a survey concerning Y2K
compliance.  Non  respondents  were sent a second survey  and/or were  contacted
directly.  Responses  from  all  critical  vendors  have  been  received  but 28
customers and 66 other vendors have not responded to our inquiries. ABT believes
that these vendor and customers will not have a material adverse impact on ABT's
operations if they are not Y2K compliant.  Year 2000 Readiness Statements are on
file for all survey  respondents.  ABT  anticipates  the process  for  obtaining
readiness statements for the remainder of its major customers and suppliers will
be  complete  no later than  November  1999.  The  responses  received  have not
indicated  any  instances  of  noncompliance  with Year 2000  that  would  cause
significant problems to ABT.

     There can be no assurance  that the failure of ABT or such third parties to
adequately  address their  respective  Year 2000 issues will not have a material
adverse effect on ABT's business, financial condition, cash flows and results of
operations.

                                      -10-
<PAGE>

     Forward Looking Statements.
     --------------------------

     You  should  also  be  aware  that  this  prospectus   supplement  contains
forward-looking   statements.   Forward   looking   statements   discuss  future
expectations,   contain  projections  of  results  of  operations  or  financial
condition,  and general  business  prospects.  Words such as  "expects,"  "may,"
"will," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and
similar expressions  identify  forward-looking  statements.  The forward-looking
statements in this prospectus  supplement reflect the good faith judgment of our
management.  However,  forward-looking statements can only be based on facts and
factors  currently  known.  Consequently,  they are not a  guarantee  of  future
performance  and actual  results and  outcomes  may differ  materially  from the
results and outcomes discussed in the forward-looking  statements. The risks and
uncertainties  that could cause or contribute  to a different  result or outcome
include  without  limitation,  total  acres of  turfgrass  and  forage  planted,
customer  purchases,  deliveries  and  payments  for ABT  products,  competitive
pricing,  weather,  effective  management  of the  integration  process and cost
reductions  at  ABT,  ability  of  ABT to  successfully  transition  to the  new
information  systems  throughout  its  operations,   customer  response  to  the
integration,  overall financial condition and asset status of ABT, relationships
with and  perceptions  of  potential  lenders and  investors,  ability to obtain
capital, litigation and other factors as detailed from time to time in ABT's SEC
filings. You should carefully consider the risk factors described above together
with all of the other information  included or incorporated by reference in this
prospectus supplement before you decide to purchase shares of our common stock.

                       WHERE YOU CAN FIND MORE INFORMATION

     ABT is subject to the information  requirements of the Securities  Exchange
Act of 1934. In  accordance  with the  Securities  Exchange Act, we file annual,
quarterly and special reports,  proxy statements and other  information with the
Securities  and  Exchange  Commission.  You may inspect and copy any document we
file at the  SEC's  public  reference  rooms in  Washington,  D.C.  at 450 Fifth
Street, N.W., Washington, D.C. 20549, and at the SEC's Northeast Regional Office
at Seven  World  Trade  Center,  New York,  New York  10048,  and at the Midwest
Regional Office at 500 West Madison Street,  Chicago,  Illinois 60611-2511.  You
may also  purchase  copies of our SEC  filings,  by writing  to the SEC,  Public
Reference  Section,  450 Fifth Street,  N.W.,  Washington,  D.C. 20549 or on the
SEC's  Worldwide  Web  site  at  http://www.sec.gov.

     This prospectus supplement is part of a registration  statement on Form S-4
that we have filed with the SEC. The SEC allows us to "incorporate by reference"
information  that we file with them.  This means that we can disclose  important
information  to you by referring you to other  documents that we have filed with
the SEC. The information that is incorporated by reference is considered part of
this  prospectus   supplement,   and   information   that  we  file  later  will
automatically update and may supersede this information. For further information
about ABT and the securities being offered, you should refer to the registration
statement and the following documents that are incorporated by reference.

     .    Our 1998 Form 10-K for the fiscal year ended June 30, 1998, amended on
          January 29, 1999 and March 31, 1999

     .    Our Quarterly Reports as follows:

          -    Form 10-QSB for March 31, 1996, amended on July 12, 1996
          -    Form 10-Q for September 30, 1998
          -    Form 10-Q for December 31, 1998
          -    Form 10-Q for March 31, 1999

                                      -11-
<PAGE>

     .    Our Current Reports on Form 8-K that we filed since July 1, 1998:

          -    Dated  October  30,  1996 and filed on  November  12,  1996,  and
               amended on January  13,  1997,  February  17, 1998 and August 11,
               1998
          -    Dated  June 23,  1998 and filed on July 8, 1998,  and  amended on
               August 28, 1998
          -    Dated  August  28,  1998 and filed on  September  11,  1998,  and
               amended on November 12, 1998 and January 29, 1999
          -    Amendment filed August 27, 1998 to report dated August 22, 1997
               and filed on September 8, 1997
          -    Dated January 6, 1998 and filed on January 16, 1998,  and amended
               on March 10, 1998, March 30, 1998,  August 11, 1998 and March 23,
               1999
          -    Dated January 9, 1998 and filed on January 20, 1998,  and amended
               on March 10, 1998, March 30, 1998 and August 11, 1998
          -    Dated  January 26, 1998 and filed on March 10, 1998,  and amended
               on March 30, 1998, August 11, 1998 and September 4, 1998
          -    Amendment  filed on August 28, 1998 to report  dated  October 22,
               1997 and filed on November 6, 1997
          -    Dated June 30, 1998 and filed on October 26, 1998
          -    Dated December 30, 1998 and filed on January 11, 1999
          -    Dated January 22, 1999 and filed on January 27, 1999
          -    Dated January 22, 1999 and filed on February 5, 1999
          -    Dated May 28, 1999 and filed on June 1, 1999
          -    Dated June 7, 1999 and filed on June 9, 1999

     .    The  description  of  our  Common  Stock,  $.001  par  value,  in  our
          registration statement on Form 8-A (File No. 0-19352),  filed July 11,
          1995,  pursuant to Section  12(g) of the  Exchange Act  including  any
          amendment or report filed for the purpose of updating such information

     .    Our Proxy  Statement  dated January 11, 1999 as amended on February 8,
          1999, for our Annual Meeting held on February 22, 1999 and

     .    All documents we file pursuant to Sections 13(a),  13(c), 14 and 15(d)
          of the Exchange Act after the date of this  prospectus  supplement and
          prior to the filing of a post-effective  amendment that indicates that
          all the securities  offered hereby have been sold or that  deregisters
          all the securities remaining unsold.

     You may request a copy of all documents that are  incorporated by reference
in this  prospectus  supplement  by writing or  telephoning  us at the following
address:  AgriBioTech,  Inc., Attention:  Chief Financial Officer, 120 Corporate
Park Drive,  Henderson,  NV 89014;  telephone  number  (702)  566-2440.  We will
provide  copies of all documents  requested (not including the exhibits to those
documents,  unless the exhibits are specifically  incorporated by reference into
those documents or this prospectus supplement) without charge.

     ABT has not  authorized  any person to give any  information or to make any
representations   in  connection  with  sales  of  the  shares  by  the  selling
stockholders  other than those  contained  in this  prospectus  supplement.  You
should not rely on any information or  representations  in connection with sales
by selling  stockholders  other than the information or  representations in this
prospectus supplement.  The information in this prospectus supplement is correct
as of the date of this prospectus  supplement.  You should not assume that there
has been no change  in the  affairs  of ABT  since  the date of this  prospectus
supplement or that the information  contained in this  prospectus  supplement is
correct  as of any time after its date.  This  prospectus  supplement  is not an
offer to sell or a solicitation  of an offer to buy shares in any  circumstances
in which such an offer or solicitation is unlawful.

                                USE OF PROCEEDS

     This prospectus supplement relates to additional shares issued to Thomas K.
Hodges,  Halina K.  Hodges  and Bill L.  Rose,  L.L.C.  in  connection  with our
acquisition  of  HybriGene,  LLC.  We  will  not  receive  any  additional  cash
consideration from the issuance of these shares.

                                      -12-
<PAGE>

                                DIVIDEND POLICY

     We have  never  declared  or paid any  dividends  on our common  stock.  We
currently  intend to retain any earnings for use in the  operation and expansion
of our business and do not  anticipate  paying any dividends on the common stock
for the foreseeable  future. Our revolving credit facility prohibits the payment
of cash dividends without the lenders' approval.

                           PRICE RANGE OF COMMON STOCK

     Our common stock has traded on the Nasdaq  National  Market since  February
14, 1997, under the symbol "ABTX."

     The  following  table  sets forth the high and low  closing  prices for the
common  stock for each  quarter in Fiscal  1997 and Fiscal  1998,  on the Nasdaq
SmallCap  Market  until  February  13,  1997 and on the Nasdaq  National  Market
thereafter.

<TABLE>
<CAPTION>

                                                    HIGH       LOW
                                                  --------   --------
     <S>                                          <C>        <C>
     FISCAL 1997
        July 1, 1996-September 30, 1996........   $ 4 1/16   $ 2 5/32
        October 1, 1996-December 31, 1996......   $ 2 3/16   $ 2 1/32
        January 1, 1997-March 31, 1997.........   $ 3 3/8    $ 2 1/16
        April 1, 1997-June 30, 1997............   $ 6 15/16  $ 2 15/32
     FISCAL 1998
        July 1, 1997-September 30, 1997........   $10 1/2    $ 6 1/32
        October 1, 1997-December 31, 1997......   $17 1/16   $ 9
        January 1, 1998-March 31, 1998.........   $19 3/32   $13 7/16
        April 1, 1998-June 30, 1998............   $29        $13 3/4
     FISCAL 1999
        July 1, 1998-September 30, 1998........   $25 3/4    $ 8 1/8
        October 1, 1998-December 31, 1998......   $17 13/16  $ 8 15/16
        January 1, 1999-March 31, 1999.........   $16 11/16  $ 3 3/4
        April 1, 1999-June 30, 1999............   $ 7 29/32  $ 5 1/8
     FISCAL 2000
        July 1, 1999-September 23, 1999........   $ 6 1/8    $ 3 21/32
</TABLE>

     As of August 31,  1999,  the Company  had 488 record  holders of its common
stock and  reasonably  believes based on information  from  shareholder  mailing
services,  that there are in excess of 20,000  beneficial  holders of its common
stock.

                                      -13-
<PAGE>

                               RECENT DEVELOPMENTS

OPERATIONS

     In addition to the restructuring and other  non-recurring  special charges,
discussed  under  "Risk  Factors"  ABT will also incur  additional  bad debt and
inventory reserves in the forth quarter of FY1999 associated with the Chapter 11
bankruptcy filing by a major customer  (Hechinger Co.) and inventory  redundancy
relating  to  integration  and  product  line  consolidation.  These  additional
reserves will not be included in the special charges. ABT will also recognize an
extraordinary  loss on the previously  announced early redemption in May 1999 of
convertible subordinated debt.

MANAGEMENT

     ABT  determined  that since it had  achieved a  leadership  position in the
forage and turfgrass seed sector, it was appropriate to change the makeup of its
Board of  Directors to reflect the need to shift to a focus on  integration  and
operations.  John C.  Francis  and  Scott  J.  Loomis,  members  of the  founder
management  team,  resigned as vice presidents of the Company and from the Board
of Directors  effective  February 1, 1999. The Board of Directors  elected Randy
Ingram  and  Thomas  B.  Rice,  officers  of ABT,  as  directors  and both  were
re-elected  directors at the February 22, 1999 annual meeting. In addition,  Dr.
Johnny R. Thomas,  a member of the founding  management team and former Chairman
and CEO,  resigned as a member of the Board and as an executive  officer of ABT,
effective  February 26, 1999. On March 24, 1999, ABT announced that Kent Schulze
resigned as a member of the Board and as an executive officer.

     On March 16, 1999,  James W. Johnston joined ABT's Board of Directors as an
outside director. Mr. Johnston, age 52, is President and Chief Executive Officer
of  Stonemarker  Enterprises,  Inc., a consulting  and  investment  company.  He
previously served as Vice Chairman of RJR Nabisco, Inc., a holding company, from
1995 to 1996.  From 1989 to 1996,  he also served as  Chairman of R.J.  Reynolds
Tobacco Co., and was Chief  Executive  Officer of that company  until 1995.  Mr.
Johnston was named a Director of RJR Nabisco Holdings Corp. in 1992 and Chairman
of R.J.  Reynolds  Tobacco  International  Inc.  in 1993.  He retired  from R.J.
Reynolds in July 1996. Mr.  Johnston  began his business  career with Ford Motor
Co. In addition  to Ford,  he has held senior  management  positions  at various
subsidiaries of Northwest Industries, Inc. and Citibank N.A. Mr. Johnston serves
on various  boards,  including  the Sealy  Corporation  and  various  non-profit
organizations.

     On June 15, 1999,  Mr. L. Glenn Orr, Jr. joined ABT's Board of Directors as
an outside director. Mr. Orr, age 59, is currently Chairman,  President & CEO of
Orr Management Company, an investment banking firm located in Winston-Salem, NC.
Earlier in his  career,  Mr. Orr spent 30 years in the  banking  industry in the
southeast U.S. He is Chairman  Emeritus of BB&T Corporation  (formerly  Southern
National Corporation), and formerly served BB&T Corporation as Chairman, CEO and
President.  Mr. Orr was  instrumental in  successfully  completing the merger of
equals between  Southern  National  Corporation  and BB&T. Mr. Orr serves on the
Board of Directors of seven  companies,  including  three other publicly  traded
companies, as well as serves on numerous non-profit boards, including service as
a Trustee  of Wake  Forest  University  and as a member  of the  North  Carolina
Economic Development Commission.

     ABT is continuing its search for additional outside directors to add to the
Board.

     ABT recently put into place a new senior  management  structure to lead the
post-integration  ABT. This change is appropriate since the integration plan has
been developed and implementation is nearing completion.  In addition to Richard
Budd, the senior  executives  are:  Kenneth Budd,  President and Chief Operating
Officer; Dr. Thomas B. Rice,  Executive Vice  President,  Director of Research;
Randy Ingram,  Executive Vice President,  Chief Financial  Officer;  and Douglas
Fisher,  Senior Vice  President,  General  Counsel,  Secretary  and  Director of
Business Services.

LEGAL PROCEEDINGS

     On June 7, 1999, ABT and Helena Chemical Company announced that the lawsuit
previously brought by Helena against ABT has been voluntarily  dismissed without
prejudice. The lawsuit, filed in Federal District Court in Memphis, Tennessee on
January 7, 1999,  arose out of the failure to close the planned  purchase by ABT
of that portion of Helena's AgriPro  agricultural  seed operations that included
alfalfa, clover and sorghum.

                                      -14-

<PAGE>

                          DESCRIPTION OF CAPITAL STOCK

AUTHORIZED

     ABT's  authorized  capital stock consists of  100,000,000  shares of common
stock,  $.001 par value,  and 10,000,000  shares of preferred  stock,  $.001 par
value.

COMMON STOCK

     We are authorized to issue  100,000,000  shares of our common stock,  $.001
par value per share, of which  48,921,281  shares were issued and outstanding as
of September  13, 1999.  All of the  outstanding  shares of our common stock are
duly  authorized,  validly  issued,  fully paid and  non-assessable.  Holders of
shares of our  common  stock are  entitled  to one vote for each  share  held of
record on all matters to be voted on by  shareholders.  There are no preemptive,
subscription,  conversion or redemption  rights  pertaining to our common stock.
Holders of shares of our common stock are entitled to receive  dividends as they
are  declared on common  stock by the Board of  Directors  out of funds  legally
available therefor and to share ratably in the assets available upon liquidation
subject to rights of creditors and any shares of preferred stock. The holders of
shares of our common stock do not have the right to cumulate  their votes in the
election of directors and,  accordingly  the holders of more than 50% of all the
our common stock outstanding are able to elect all directors.

PREFERRED STOCK

     ABT is authorized to issue 10,000,000 shares of preferred stock,  $.001 par
value per share.  As of the date  hereof,  we had no shares of  preferred  stock
issued and outstanding.

     The preferred  stock may be divided by the Board of Directors  from time to
time into one or more series.  The Board of Directors is authorized to determine
the rights,  preferences,  privileges and  restrictions,  including the dividend
rights, conversion rights, voting rights, terms of redemption (including sinking
fund provisions, if any) and liquidation preferences, of any series of preferred
stock and to fix the number of shares of any series  without any further vote or
action by stockholders. At present, we have no plans, proposals,  commitments or
arrangements  to issue  any  shares  of  preferred  stock.  Our  Certificate  of
Incorporation  authorizes  the  issuance of preferred  stock with  designations,
rights,  and  preferences as may be determined from time to time by the Board of
Directors. Accordingly, the Board of Directors is empowered, without stockholder
approval,  to issue  preferred  stock with  dividend,  liquidation,  conversion,
voting or other  rights that could  adversely  affect the voting  power or other
rights of the holders of the common stock.  Although the preferred  stock may be
used for any lawful  purpose,  we have agreed not to use it as an  anti-takeover
device  that  could  be  utilized  as a  method  of  discouraging,  delaying  or
preventing  a change in control  of the  company  without  the  approval  of our
stockholders.

WARRANTS

     On December 30, 1998 and January 5, 1999, we issued  1,703,000  warrants to
purchase  shares of our common stock.  These warrants were issued along with our
5% convertible  debentures to six qualified  institutional buyers and accredited
investors in private placements. These warrants were purchased for $1.00 and are
exercisable at $15.00 per share for three years commencing on their issue dates.
The warrants are subject to mandatory  conversion  on five prior  business  days
notice if the closing sale price of our common  stock  exceeds $25 per share for
20 trading days out of any 30 consecutive  trading days ending within l5 days of
our mailing notice of the  conversion,  provided  there is a current  prospectus
covering the  underlying  common stock.  The shares of ABT common stock issuable
upon exercise of the warrants have been  registered  for resale under a separate
registration  statement.  The holders of the warrants and ABT have agreed not to
exercise  warrants  if the  holder  would  then  own in  excess  of  4.9% of ABT
outstanding common stock following the exercise of the warrant.

                                     -15-
<PAGE>

     On  December 4, 1998,  we issued  600,000  warrants to purchase  our common
stock to three  qualified  institutional  buyers  and  accredited  investors  in
private  placements of units. Each unit was sold for $13.50 and consisted of one
share of common stock and one warrant.  The warrants are  exercisable at a price
of $15.00 per share for three years  commencing  on their date of issuance.  The
warrants are subject to mandatory  conversion on five prior business days notice
if the closing  sale price of our common stock  exceeds  $25.00 per share for 20
trading days out of any 30 consecutive trading days ending within 15 days of our
mailing  notice of the  conversion.  The shares of common  stock  issuable  upon
exercise  of the  warrants  have been  registered  for  resale  under a separate
registration statement.

     On August 28, 1998, we issued 886,410 warrants to purchase our common stock
to five  qualified  institutional  buyers and  accredited  investors  in private
placements.  The warrants were sold for $2.00 per Warrant and are exercisable at
$12.00  per share for three  years  commencing  on their date of  issuance.  The
warrants are subject to  redemption  at $.01 per warrant on five prior  business
days' notice if the closing  sale price of the  Company's  common stock  exceeds
$19.50  per share for 20  trading  days out of any 30  consecutive  trading  day
period ending  within 15 days of our mailing  notice of the  conversion  and the
holder  fails  to  exercise  the  warrant.  As of the  date of  this  prospectus
supplement,  556,410 of these  warrants  have been  tendered back to us with the
exercise price in exchange for shares of common stock  registered as part of our
Universal Shelf  Registration  Statement (No.  333-61127.) The remaining 330,000
shares  of  common  stock  issuable  upon  exercise  of the  warrants  have been
registered for resale under a separate registration statement.

     On May 4, 1998 and May 13, 1998,  respectively,  we issued 241,600 warrants
and 344,900  redeemable  warrants to purchase shares of our common stock.  These
warrants  were  issued to six  qualified  institutional  buyers  and  accredited
investors  in  private  placements  of units.  Each unit was sold for $29.00 and
consisted  of two shares of common  stock and one  warrant.  These  warrants are
exercisable  at a price of $17.50 per share for three years  commencing on their
respective dates of issuance.  The redeemable warrants are subject to redemption
at $.01 per warrant on five prior  business  days'  notice if the  closing  sale
price of our common stock exceeds  $25.00 per share for 15  consecutive  trading
days and the  Company  notifies  the  holder  it  intends  to force a  mandatory
conversion  of the warrants  and the holder  fails to exercise the warrant.  The
shares of common  stock  issuable  upon  exercise  of these  warrants  have been
registered for resale under a separate registration statement.

     We have the right to reduce the exercise  price and/or  extend the exercise
period at its  discretion,  and/or make other  inducements to warrant holders to
encourage early exercise of warrants.

REGISTRAR AND TRANSFER AGENT

     The  Registrar and Transfer  Agent for our common stock is Corporate  Stock
Transfer, Inc., Denver, Colorado.

                              PLAN OF DISTRIBUTION

     All of the shares being  offered by this  prospectus  supplement  are being
issued by ABT to Thomas K. Hodges and Halina K. Hodges and Bill L. Rose,  L.L.C.
under a stock  purchase  agreement  dated January 22, 1999. The shares have been
registered on ABT's Registration  Statement on Form S-4 (No. 333-61097) of which
this  prospectus  supplement  forms a part.  Pursuant  to the terms of the stock
purchase agreement, we will pay all expenses incident to this issuance.

                     COMMISSION POSITION ON INDEMNIFICATION
                         FOR SECURITIES ACT LIABILITIES

     Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors,  officers and  controlling  persons of the issuer
pursuant to the foregoing provisions or otherwise,  we have been advised that in
the  opinion  of the SEC  such  indemnification  is  against  public  policy  as
expressed in the Act and is, therefore, unenforceable.

                                  LEGAL MATTERS

     The  validity  of the shares  offered  hereby has been  passed upon by Snow
Becker Krauss P.C.,  605 Third  Avenue,  New York,  New York 10158.  Snow Becker
Krauss P.C. owns 43,823 shares of our common stock,  and  individual  members of
the firm own additional shares of common stock.

                                      -16-
<PAGE>

                                    EXPERTS

     The consolidated financial statements and schedule of AgriBioTech,  Inc. as
of June 30,  1998 and 1997 and for each of the  years in the  three-year  period
ended June 30, 1998 are incorporated by reference herein and in the registration
statement in reliance upon the report of KPMG LLP, independent  certified public
accountants,  incorporated by reference  herein,  and upon the authority of said
firm as experts in accounting and auditing.

     The financial  statements of Beachley Hardy Seed Company as of December 31,
1995 and 1994 and for the years then ended have been  incorporated  by reference
herein in reliance  upon the report of KPMG LLP,  independent  certified  public
accountants,  incorporated  by reference  herein and upon the  authority of said
firm as experts in accounting and auditing.

     The combined financial statements of Germain's Inc. and W-L Research,  Inc.
as of  September  30,  1995 and 1994 and for the  years  then  ended  have  been
incorporated  by  reference  herein  in  reliance  upon the  report of KPMG LLP,
independent  certified public accountants,  incorporated by reference herein and
upon the authority of said firm as experts in accounting and auditing.

     The combined financial statements of Seed Corporation of America,  Inc. and
Green Seed Company Limited  Partnership as of December 31, 1997 and 1996 and for
the years then ended have been incorporated by reference herein in reliance upon
the report of KPMG LLP, independent  certified public accountants,  incorporated
by reference herein and upon the authority of said firm as experts in accounting
and auditing.

     The financial  statements  of Lofts Seed,  Inc. as of November 30, 1997 and
December 31, 1996 and for the  eleven-month  period ended  November 30, 1997 and
the six-month period ended December 31, 1996 have been incorporated by reference
herein in reliance  upon the report of Cannon & Company,  independent  certified
public  accountants,  incorporated by reference herein and upon the authority of
said firm as experts in accounting and auditing.

     The financial  statements of Lofts Seeds, Inc. as of June 30, 1996 and 1995
and for the years then  ended  have been  incorporated  by  reference  herein in
reliance upon the report of Amper,  Politziner & Mattia,  independent  certified
public  accountants,  incorporated by reference herein and upon the authority of
said firm as experts in accounting and auditing.

     The  financial  statements  of Budd Seed,  Inc. as of November 30, 1997 and
December 31, 1996 and 1995 and for the ten-month  period ended November 30, 1997
and the  years  ended  December  31,  1996 and 1995 have  been  incorporated  by
reference  herein in reliance  upon the report of Cannon & Company,  independent
certified  public  accountants,  incorporated  by reference  herein and upon the
authority of said firm as experts in accounting and auditing.

     The financial statement of Willamette Seed Co. as of June 30, 1997 and 1996
and for the years then  ended  have been  incorporated  by  reference  herein in
reliance on the report of Price, Koontz & Davies,  P.C.,  independent  certified
public  accountants,  incorporated by reference herein and upon the authority of
said firm as experts in accounting and auditing.

     The financial statements of Allied Seed Company, Inc. (a division of Agway,
Inc.) as of June 30, 1998 and 1997 and for the years then ended are incorporated
by reference in reliance on the report of KPMG LLP, independent certified public
accountants,  incorporated  by reference  herein and upon the  authority of said
firm as experts in accounting and auditing.

     The financial Statements of Oseco Inc. as of June 30, 1998 and for the year
then ended are  incorporated  by reference in reliance on the report of KPMG LLP
Chartered Accountants incorporated by reference herein and upon the authority of
said firm as experts in accounting and auditing.

     The financial  Statements of HybriGene LLC, as of December 31, 1998 and for
the year then ended are  incorporated  by reference in reliance on the report of
Huth  Thompson LLC  incorporated  by reference  herein and upon the authority of
said firm as experts in accounting and auditing.

     The financial  statements of SeedBiotics,  L.L.C.,  as of December 31, 1998
and for the year then ended are  incorporated  by  reference  in reliance on the
report of Ripley Doorn & Company, P.L.L.C.  incorporated by reference herein and
upon the authority of said firm as experts in accounting and auditing.

                                      -17-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission